Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

Equities

603811

CNE100002YC7

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
8.3 CNY +1.10% Intraday chart for Zhejiang Cheng Yi Pharmaceutical Co., Ltd. +10.37% -19.96%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Cheng Yi Pharmaceutical Shareholder Boosts Stake in Firm MT
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Cheng Yi Pharmaceutical Gains Nod to Market Osteoarthritis Drug Ingredient MT
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Shenzhen Youli Investment Management Co., Ltd. intends to acquire 5.82% stake in Zhejiang Cheng Yi Pharmaceutical Co., Ltd. from Yan Yiyi for approximately CNY 170 million. CI
Zhejiang Cheng Yi Pharma's Shareholder to Unload 5.82% Stake CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Wenzhou Guanhui Enterprise Management Co., Ltd. signed an equity transfer agreement to acquire 27.5% stake in Wenzhou Dongtou District Sincerity Microfinance Co., Ltd. from Zhejiang Cheng Yi Pharmaceutical Co., Ltd. for CNY 24.4 million. CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Declares Distribution for the Year 2019, Payable on June 3, 2020 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Certain A Shares of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 15-MAR-2020. CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019 CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Announces Earnings Guidance for the First Half of 2019 CI
Chart Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
More charts
Zhejiang Cheng Yi Pharmaceutical Co., Ltd is a China-based company principally engaged in the research, development, production and sales of bulk pharmaceutical chemicals of chemical medicine and preparations. The Company’s products are on the spectrum from arthritis, dieresis to anti-virus and anti-tumor. The main products include bulk pharmaceutical chemicals, injections, capsules, intermediates and others.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 603811 Stock
  4. News Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
  5. Cheng Yi Pharmaceutical Shareholder Boosts Stake in Firm